Delisting risk
Curanex Pharmaceuticals (CURX)
Develops a botanical drug candidate for ulcerative colitis and inflammatory diseases.
$4.55
At close+0.05 (+1.11%)
Something off on this page? Send us feedback.
EPSReportedEstimate
—————Nov '25Mar '26Aug '26
Reported—————−$0.04−$0.12−$0.60
Estimate————————
Surprise————————
RevenueReportedEstimate
—————Nov '25Mar '26Aug '26
Reported————————
Estimate————————
Surprise————————
History
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Aug 2026 | — | −$0.60 | — |
| Mar 2026 | — | −$0.12 | — |
| Nov 2025 | — | −$0.04 | — |
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | — | −$0.60 | — | — | — | — | −0.9% |
| Mar 30, 2026 | — | −$0.12 | — | — | — | — | +4.8% |
| Nov 14, 2025 | — | −$0.04 | — | — | — | — | +2.5% |